(Q78206933)
Statements
The Trk tyrosine kinase inhibitor CEP-701 (KT-5555) exhibits significant antitumor efficacy in preclinical xenograft models of human pancreatic ductal adenocarcinoma (English)
Miknyoczki SJ
Chang H
Klein-Szanto A
Dionne CA